While the exact causal relationship requires further investigation, both COVID-19 infection and systemic lupus erythematosus (SLE) have been implicated in the potential induction of TTP through mechanisms such as direct endothelial damage, production of anti-ADAMTS-13 antibodies, and autoimmune responses. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.